RiboTargets antibiotic deal with JNJ

RiboTargets ( Cambridge, U.K.) will provide the R.W. Johnson Pharmaceutical Research Institute, a subsidiary of Johnson & Johnson (JNJ), with two bacterial ribosome targets, and compounds that are act...